Could Cognitive Behavioural Therapy Be an Effective Treatment for Long COVID and Post COVID-19 Fatigue Syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome

Mark Vink, Alexandra Vink-Niese, Mark Vink, Alexandra Vink-Niese

Abstract

An increasing number of young and previously fit and healthy people who did not require hospitalisation continue to have symptoms months after mild cases of COVID-19. Rehabilitation clinics are already offering cognitive behavioural therapy (CBT) as an effective treatment for long COVID and post-COVID-19 fatigue syndrome based on the claims that it is effective for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-the most common post-infectious syndrome-as no study into the efficacy of CBT for post-COVID-19 fatigue syndrome has been published. Re-analyses of these studies, however, showed that CBT did not lead to objective improvements in heterogeneous groups of ME/CFS patients, nor did it restore the ability to work. The group of patients with long COVID and post-COVID-19 fatigue syndrome, on the other hand, is homogeneous. We therefore analysed the Dutch Qure study, as it studied the efficacy of CBT in a homogeneous group of patients who developed Q-fever fatigue syndrome-which affects up to 30% of patients-after the largest reported outbreak of Q-fever, to see if CBT might potentially be an effective treatment for long-haulers after COVID-19 infection. Our reanalysis found that the Qure study suffered from many serious methodological problems, which included relying on one subjective primary outcome in a study without a control group for the non-blinded CBT treatment group, using a post hoc definition of improvement, waiting 2 years before publishing their objective actometer results and ignoring the null effect of said results. Moreover, only 10% of participants achieved a clinically meaningful subjective improvement in fatigue as a result of CBT according to the study's own figures. Consequently, CBT has no subjective clinically meaningful effect in nine out of every ten patients that are treated with it. Additionally, the subjective improvement in fatigue was not matched by an improvement in disability, even though the disability was fatigue related according to the researchers. On top of this, CBT did not lead to an objective improvement in physical performance. Therefore, it cannot be said that CBT is an effective treatment for Q-fever fatigue syndrome either. It seems therefore unlikely that CBT will reduce disability or lead to objective improvement in long COVID or in post-COVID-19 fatigue syndrome.

Keywords: CBT; ME/CFS; actometer; chronic fatigue syndrome; cognitive behavioural therapy; disability; long COVID; myalgic encephalomyelitis/chronic fatigue syndrome; post-COVID-19 fatigue syndrome.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Goërtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6 doi: 10.1183/23120541.00542-2020.
    1. WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization, Geneva. [(accessed on 14 October 2020)];2020 Oct 14; Available online: .
    1. Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603–605. doi: 10.1001/jama.2020.12603.
    1. Sigfrid L., Jesudason E., Lim W.S., Rello J., Amuasi H., Drake T.M., Bozza F., Palmieri C., Munblit D., Holter J.C., et al. What is the Recovery Rate and Risk of Long-Term Consequences from COVID-19?—A Harmonised, Global Observational Study Protocol. [(accessed on 24 October 2020)]; Available online: .
    1. Rayner C., Lokugamage A., Molokhia M. Covid-19: Prolonged and relapsing course of illness has implications for returning workers. [(accessed on 10 December 2020)]; Available online:
    1. Islam M.F., Cotler J., Jason L.A. Post-viral fatigue and COVID-19: Lessons from past epidemics. Fatigue Biomed. Health Behav. 2020;8:61–69. doi: 10.1080/21641846.2020.1778227.
    1. Topol E.J., Verghese A., Fauci A.S. Fauci to Medscape: ‘We’re All in It Together and We’re Gonna Get Through It’. [(accessed on 24 October 2020)]; Available online: .
    1. Garner P. On Long Haul COVID-19—Don’t try to Dominate This Virus, Accommodate It. [(accessed on 24 October 2020)]; Available online:
    1. Davis H. People w’ #LongCovid—We Need to Be Uniformly Rejecting CBT & Programs w’ Only CBT as Treatment. [(accessed on 28 November 2020)]; Available online: .
    1. Alwan N. People Ill with #LongCovid Seeking Medical Help Need Tests and Investigations to Rule Out Any Underlying Treatable Problem. [(accessed on 5 December 2020)]; Available online: .
    1. Faas J. Post-Covid: ME/CVS Revisited Medisch Contact. [(accessed on 28 November 2020)]; Available online: .
    1. Oxford Health NHS Foundation Trust, OHFT Psychosocial Response Group Coping with Coronavirus Fatigue. [(accessed on 24 October 2020)]; Available online: .
    1. Miller A., Royal Society of Medicine RSM webinar #RSMLive RSM COVID-19 Series. Episode 43: Long COVID: Understanding the Shadow of the Virus CBT and GET Are Effective Treatments for long COVID, PVFS and ME/CFS. [(accessed on 10 December 2020)]; Available online: .
    1. Tuller D. Trial by Error: And Now–No Surprise–CBT for Post-Covid Fatigue. [(accessed on 28 November 2020)]; Available online:
    1. Tuller D. Trial by Error: That Royal Society of Medicine Webinar on Long-Covid. [(accessed on 28 November 2020)]; Available online:
    1. Li J., Li X., Jiang J., Xu X., Wu J., Xu Y., Lin X., Hall J., Xu H., Xu J., et al. The Effect of Cognitive Behavioral Therapy on Depression, Anxiety, and Stress in Patients with COVID-19: A Randomized Controlled Trial. Front. Psychiatry. 2020;11 doi: 10.3389/fpsyt.2020.580827.
    1. Vink M., Vink-Niese A. Cognitive behavioural therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective. Re-analysis of a Cochrane review. Health Psychol. Open. 2019;6 doi: 10.1177/2055102919840614.
    1. Vink M., Vink-Niese F. Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies. Diagnostics. 2019;9:124. doi: 10.3390/diagnostics9040124.
    1. Keijmel S.P., Delsing C.E., Bleijenberg G., Van Der Meer J.W.M., Donders R.T., Leclercq M., Kampschreur L.M., Berg M.V.D., Sprong T., Nabuurs-Franssen M.H., et al. Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial. Clin. Infect. Dis. 2017;64:998–1005. doi: 10.1093/cid/cix013.
    1. Mares-Guia M.A.M., Guterres A., Rozental T., Ferreira M.D.S., De Lemos E.R.S. Clinical and epidemiological use of nested PCR targeting the repetitive element IS 1111 associated with the transposase gene from Coxiella burnetii. Braz. J. Microbiol. 2018;49:138–143. doi: 10.1016/j.bjm.2017.04.009.
    1. Anderson A., Bijlmer H., Fournier P.E., Graves S., Hartzell J., Kersh G.J., Limonard G., Marrie T.J., Massung R.F., McQuiston J.H., et al. Diagnosis and management of Q-fever—United States, 2013: Recommendations from CDC and the Q-fever Working Group. Morb. Mortal. Wkly. Rep. Recomm. Rep. 2013;62:1–30.
    1. Van Orsouw W. Sporten met Q-koorts: Visies van de Stakeholders De Problemen en Oplossingen bij Sporten met het Q-Koortsvermoeidheidssyndroom (QVS) 16 January 2015. [(accessed on 24 October 2020)]; Available online: .
    1. Grobben C.M. AANSPRAKELIJKHEID VOOR Q-KOORTSSCHADE Een Onderzoek Naar de Obstakels en Oplossingen bij Aansprakelijkstelling voor Q-Koortsschade Afstudeerscriptie Juridische Faculteit Universiteit van Tilburg. [(accessed on 24 October 2020)];2013 (In Dutch) Available online: .
    1. Morroy G., Keijmel S.P., Delsing C.E., Bleijenberg G., Langendam M., Timen A., Bleeker-Rovers C.P. Fatigue following Acute Q-Fever: A Systematic Literature Review. PLoS ONE. 2016;11 doi: 10.1371/journal.pone.0155884.
    1. Lam M.H., Wing Y.K., Yu M.W., Leung C.M., Ma R.C., Kong A.P., So W.Y., Fong S.Y., Lam S.P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 2009;169:2142–2147. doi: 10.1001/archinternmed.2009.384.
    1. RIVM LCI-richtlijn Q-koortsvermoeidheidssyndroom (QVS) Dutch Guideline Q-Fever Fatigue Syndrome (QFS) [(accessed on 24 October 2020)];2019 Jul 1; (In Dutch) Available online: .
    1. The Q-fever SoNG Working Group Q-fever CDNA National Guidelines for Public Health Units Version 1.0. [(accessed on 24 October 2020)];2018 Jan 8; Available online: .
    1. Raijmakers R., Keijmel S.P., Breukers E.M., Bleijenberg G., Van Der Meer J.W., Bleeker-Rovers C.P., Knoop H. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study. J. Psychosom. Res. 2019;116:62–67. doi: 10.1016/j.jpsychores.2018.11.007.
    1. Breukers E.M., Raijmakers R., Nieuwkerk P., Bleijenberg G., Van Der Meer J.W.M., Bleeker-Rovers C.P., Keijmel S.P., Knoop H. Mediation analysis shows that a decline in self-efficacy mediates the increase in fatigue severity following an initial positive response to cognitive behavioural therapy in Q fever fatigue syndrome. J. Psychosom. Res. 2019;127 doi: 10.1016/j.jpsychores.2019.109841.
    1. Keijmel S.P., Delsing C.E., Sprong T., Bleijenberg G., Van Der Meer J.W.M., Knoop H., Bleeker-Rovers C.P. The Qure study: Q fever fatigue syndrome—Response to treatment; a randomized placebo-controlled trial. BMC Infect. Dis. 2013;13 doi: 10.1186/1471-2334-13-157.
    1. Knoop H., Bleijenberg G., Gielissen M.F., van der Meer J.W., White P.D. Is a Full Recovery Possible after Cognitive Behavioural Therapy for Chronic Fatigue Syndrome? Psychother. Psychosom. 2007;76:171–176. doi: 10.1159/000099844.
    1. Keijmel S.P., Bleijenberg G., van der Meer J.W.M., Knoop H., Bleeker-Rovers C.P. Reply to Raoult. Clin. Infect. Dis. 2017;65:1055–1056. doi: 10.1093/cid/cix470.
    1. Keijmel S.P., Saxe J., Van Der Meer J.W., Nikolaus S., Moorlag S.J., Bleijenberg G., Bleeker-Rovers C.P., Knoop H. A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour. J. Psychosom. Res. 2015;79:295–302. doi: 10.1016/j.jpsychores.2015.07.005.
    1. The Qure Study: Q-Fever Fatigue Syndrome—Response to Treatment (Qure) [(accessed on 10 December 2020)]; Available online: .
    1. Evans S. When and How Can Endpoints be Changed after Initiation of a Randomized Clinical Trial? PLoS Clin. Trials. 2007;2 doi: 10.1371/journal.pctr.0020018.
    1. Keijmel S.P. The Qure Study. Trial NL2669 (NTR2797) [(accessed on 24 October 2020)]; Available online: .
    1. Coyne J.C. Danish RCT of Cognitive Behavior Therapy for Whatever Ails Your Physician about You, Mind the Brain. [(accessed on 24 October 2020)];2016 Dec 7; Available online:
    1. Lilienfeld S.O., Ritschel L.A., Lynn S.J., Cautin R.L., Latzman R.D. Why Ineffective Psychotherapies Appear to Work: A Taxonomy of Causes of Spurious Therapeutic Effectiveness. Perspect. Psychol. Sci. 2014;9:355–387. doi: 10.1177/1745691614535216.
    1. Wood L., Egger M., Gluud L.L., Schulz K.F., Jüni P., Altman D.G., Gluud C., Martin R.M., Wood A.J.G., Sterne J.A.C. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. BMJ. 2008;336:601–605. doi: 10.1136/.
    1. Hróbjartsson A., Emanuelsson F., Thomsen A.S.S., Hilden J., Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. Int. J. Epidemiol. 2014;43:1272–1283. doi: 10.1093/ije/dyu115.
    1. The EU Clinical Trials Register. [(accessed on 10 December 2020)]; Available online: .
    1. Belluz J. How Researchers Dupe the Public with a Sneaky Practice Called “Outcome Switching”. [(accessed on 24 October 2020)]; Available online: .
    1. Ioannidis J.P.A. Why most published research findings are false. PLoS Med. 2005;2 doi: 10.1371/journal.pmed.0020124.
    1. McCoy C. Understanding the Intention-to-treat Principle in Randomized Controlled Trials. West. J. Emerg. Med. 2017;18:1075–1078. doi: 10.5811/westjem.2017.8.35985.
    1. Abraha I., Cozzolino F., Orso M., Marchesi M., Germani A., Lombardo G., Eusebi P., De Florio R., Luchetta M.L., Iorio A., et al. A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews. J. Clin. Epidemiol. 2017;84:37–46. doi: 10.1016/j.jclinepi.2016.11.012.
    1. Heneghan C., Goldacre B., Mahtani K.R., Heneghan C., Goldacre B., Mahtani K.R. Why clinical trial outcomes fail to translate into benefits for patients. Trials. 2017;18:1–7. doi: 10.1186/s13063-017-1870-2.
    1. Rongen-van Dartel S.A.A., Repping-Wuts H., van Hoogmoed D., Knoop H., Bleijenberg G., van Riel P.L., Fransen J. Relationship between objectively assessed physical activity and fatigue in patients with rheumatoid arthritis: Inverse correlation of activity and fatigue. Arthritis Care Res. 2014;66:852–860. doi: 10.1002/acr.22251.
    1. Savović J., Jones H., Altman D., Harris R., Jűni P., Pildal J., Als-Nielsen B., Balk E., Gluud C., Gluud L., et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: Combined analysis of meta-epidemiological studies. Health Technol. Assess. 2012;16:1–82. doi: 10.3310/hta16350.
    1. Whiting P., Bagnall A.M., Sowden A.J., Cornell J.E., Mulrow C.D., Ramírez G. Interventions for the Treatment and Management of Chronic Fatigue Syndrome: A Systematic Review. JAMA. 2001;286:1360–1368. doi: 10.1001/jama.286.11.1360.
    1. Wechsler M.E., Kelley J.M., Boyd I.O., Dutile S., Marigowda G., Kirsch I., Israel E., Kaptchuk T.J. Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma. N. Engl. J. Med. 2011;365:119–126. doi: 10.1056/NEJMoa1103319.
    1. Yu R., Chen L. The need to control for regression to the mean in social psychology studies. Front. Psychol. 2015;5 doi: 10.3389/fpsyg.2014.01574.
    1. Barnett A., Van Der Pols J.C., Dobson A.J. Regression to the mean: What it is and how to deal with it. Int. J. Epidemiol. 2004;34:215–220. doi: 10.1093/ije/dyh299.
    1. Schnuerch R., Schnuerch M., Gibbons H. Assessing and correcting for regression toward the mean in deviance-induced social conformity. Front. Psychol. 2015;6 doi: 10.3389/fpsyg.2015.00669.
    1. Linden A. Assessing regression to the mean effects in health care initiatives. BMC Med. Res. Methodol. 2013;13 doi: 10.1186/1471-2288-13-119.
    1. Wiborg J.F., Knoop H., Stulemeijer M., Prins J.B., Bleijenberg G. How does cognitive behaviour therapy reduce fatigue in patients with chronic fatigue syndrome? The role of physical activity. Psychol. Med. 2010;40:1281–1287. doi: 10.1017/S0033291709992212.
    1. Knoop H., Van Der Meer J.W.M., Bleijenberg G. Guided self-instructions for people with chronic fatigue syndrome: Randomised controlled trial. Br. J. Psychiatry. 2008;193:340–341. doi: 10.1192/bjp.bp.108.051292.
    1. Prins J.B., Bleijenberg G., Bazelmans E., Elving L.D., De Boo T.M., Severens J.L., Van Der Wilt G.J., Spinhoven P., Van Der Meer J.W. Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet. 2001;357:841–847. doi: 10.1016/S0140-6736(00)04198-2.
    1. Stulemeijer M., de Jong L.W., Fiselier T.J., Hoogveld S.W., Bleijenberg G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: Randomised controlled trial. BMJ. 2004;330 doi: 10.1136/bmj.38301.587106.63.
    1. RIVM Multidisciplinaire LCI-richtlijn Q-koortsvermoeidheidssyndroom (QVS) Dutch Guideline Q-fever Fatigue Syndrome (QFS) [(accessed on 24 October 2020)];2012 Mar; (In Dutch) Available online: .
    1. Cuijpers P., Cristea I.A. How to prove that your therapy is effective, even when it is not: A guideline. Epidemiol. Psychiatr. Sci. 2015;25:428–435. doi: 10.1017/S2045796015000864.
    1. Lubet S. Investigator bias and the PACE trial. J. Health Psychol. 2017;22:1123–1127. doi: 10.1177/1359105317697324.
    1. Dragioti E., Dimoliatis I.D.K., Fountoulakis K.N., Evangelou E. A systematic appraisal of allegiance effect in randomized controlled trials of psychotherapy. Ann. Gen. Psychiatry. 2015;14 doi: 10.1186/s12991-015-0063-1.
    1. Meyer K., Schwaibolda M., Westbrook S., Beneke R., Hajric R., Lehmann M., Roskamm H. Effects of exercise training and activity restriction on 6-minute walking test performance in patients with chronic heart failure. Am. Heart J. 1997;133:447–453. doi: 10.1016/S0002-8703(97)70187-X.
    1. Tolin D.F. Is cognitive–behavioral therapy more effective than other therapies? A meta-analytic review. Clin. Psychol. Rev. 2010;30:710–720. doi: 10.1016/j.cpr.2010.05.003.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner